No products in the cart.
Molnupiravir improves outcomes in non-hospitalized COVID-19 patients
1. In coronavirus disease 2019 (COVID-19) patients, molnupiravir was associated with earlier and larger reductions of C-reactive protein (CRP) as...
Infectious Disease
Reports of high-impact infectious disease studies by medical professionals
Human papillomavirus (HPV) vaccination rates have increased in recent years
1. Between 2015 and 2020, human papillomavirus vaccination (HPV) rates in the United States increased, especially amongst adolescent males. 2. Those...
Risk of myocarditis or pericarditis after COVID-19 mRNA vaccination is highest among younger males
1. The highest incidence of myocarditis or pericarditis was seen after the second dose of Moderna (mRNA-1273) in young men...
AZD7442 monoclonal antibodies are efficacious in the prevention of COVID-19
1. Compared to placebo, intramuscular AZD7442 had a relative risk reduction of 76.7% for symptomatic incident coronavirus disease 2019 (COVID-19)....
The Moderna mRNA vaccine prevents COVID-19 infection in adolescents
1. The Moderna mRNA vaccine significantly decreased the risk of contracting coronavirus disease 2019 (COVID-19) in adolescents. 2. For adolescents...
Small-magnitude differences in risk of adverse events identified between the BNT162b2 and mRNA-1273 across 38 weeks follow-up
1. Among a large cohort of US veterans, the 38-week risks of adverse events were low in both vaccine groups,...
Religious communities may have played both beneficial and detrimental roles during the COVID-19 pandemic
1. In response to the COVID-19 pandemic, religious communities have had a positive impact through collaboration with government, cancelling in-person...
Human Papillomavirus self-sampling may be a culturally-sensitive alternative for Muslim women
1. This study identified positive aspects of Human Papillomavirus (HPV) self-sampling, included privacy and modesty, convenience, increased comfort and decreased...
Sotrovimab reduces the severity of COVID-19 progression
1. In patients with mild-to-moderate coronavirus disease 2019 (COVID-19), sotrovimab reduced the risk of disease progression. 2. Sotrovimab was associated...
The ZF2001 vaccine is safe and effective at preventing COVID-19 in adults
1. The ZF2001 vaccine significantly reduces the risk of contracting symptomatic coronavirus disease 2019 (COVID-19) as compared to a placebo...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.